Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03538444 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
A NA study, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03538444: Clinical Trial NA study, sponsored by Medical University of South Carolina.
NCT03538444 is a NA study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03538444, a NA study, was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This double-blind, randomized, controlled trials will investigate the effect of accelerated, repeated transcranial magnetic stimulation on opiate craving and perceived pain .
Primary Outcome
Change in cue-induced craving ratings on 10 point Likert Scales. 0=Not at all; 10=Extremely How much do you WANT TO USE \_(opiate of choice)\_ right now? HOW HARD would it be for you TO RESIST USING\_(opiate of choice)\_ right now if it was offered to you? How much do you currently crave opiates? (scores on each of those questions are summed to be between 0 and 30 with 30 being the highest (and indicating the most craving).
Interventions
- DEVICE Sham rTMS
- DEVICE Repetitive Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-09-28 |
| Est. Completion | 2020-05-01 |
| Phase | NA |
Why NCT03538444 stopped before completion
NCT03538444 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham rTMS is the first listed.
NCT03538444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03538444 about?
NCT03538444 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder". This double-blind, randomized, controlled trials will investigate the effect of accelerated, repeated transcranial magnetic stimulation on opiate craving and perceived pain .
What is the current status of trial NCT03538444?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2018-09-28. Estimated completion is 2020-05-01.
What interventions are being tested in trial NCT03538444?
The interventions under investigation include: Sham rTMS (DEVICE), Repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03538444?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03538444's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI